Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Jun;66(2):185–190. doi: 10.1111/j.1476-5381.1979.tb13663.x

Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.

L F Tseng
PMCID: PMC2043623  PMID: 313827

Abstract

1 Activation of mycolonic twitch activity (MTA) of suprahyoideal muscle after p-methoxyamphetamine (PMA) administration in rats anaesthetized with urethane has previously been reported to be due to brain 5-hydroxytryptamine (5-HT) release. Increased MTA caused by PMA was blocked by chlorimipramine (0.1 to 1 mg/kg) and fluoxetine (0.3 to 3 mg/kg) but not by desipramine (3 mg/kg). 2 The 5-hydroxytryptophan-induced increase of MTA of suprahyoideal muscle in rats pretreated with pargyline was not blocked by chlorimipramine but was blocked by methysergide. 3 [3H]-5-HT was injected intraventricularly 30 min before the beginning of ventricular perfusion with artificial cerebrospinal fluid in urethane anaesthetized rats. PMA (mg/kg i.v.) increased the release of [3H]-5-HT in the perfusate after injection. Chlorimipramine (0.1 to 1 mg/kg) and fluoxetine (0.1 to 1 mg/kg), injected 10 min before the PMA injection, caused a dose-related blockade of the increased release of [3H]-5-HT induced by PMA. Desipramine at 3 mg/kg slightly inhibited the increased release of [3H]-5-HT caused by PMA but was inactive at 1 mg/kg. 4 It is proposed that these 5-HT uptake inhibitors block the increased MTA caused by PMA by preventing the PMA-induced release of 5-HT in the central nervous system.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azzaro A. J., Ziance R. J., Rutledge C. O. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue. J Pharmacol Exp Ther. 1974 Apr;189(1):110–118. [PubMed] [Google Scholar]
  2. Bieger D., Larochelle L., Hornykiewicz O. A model for the quantitative study of central dopaminergic and serotoninergic activity. Eur J Pharmacol. 1972 Apr;18(1):128–136. doi: 10.1016/0014-2999(72)90140-9. [DOI] [PubMed] [Google Scholar]
  3. Carlsson A. Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices. J Pharm Pharmacol. 1970 Oct;22(10):729–732. doi: 10.1111/j.2042-7158.1970.tb08419.x. [DOI] [PubMed] [Google Scholar]
  4. Chutkow J. G. Magnesium and calcium in the cerebrospinal fluid of the rat. Proc Soc Exp Biol Med. 1968 Jun;128(2):555–558. doi: 10.3181/00379727-128-33064. [DOI] [PubMed] [Google Scholar]
  5. Fuller R. W., Perry K. W., Molloy B. B. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J Pharmacol Exp Ther. 1975 Jun;193(3):793–803. [PubMed] [Google Scholar]
  6. Hirvonen J., Karlsson L. K., Salorinne Y. Cerebrospinal fluid perfusion, a method for the study of neurosecretory organs. Acta Physiol Scand. 1969 Apr;75(4):636–640. doi: 10.1111/j.1748-1716.1969.tb04417.x. [DOI] [PubMed] [Google Scholar]
  7. Lidbrink P., Jonsson G., Fuxe K. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology. 1971 Sep;10(5):521–536. doi: 10.1016/0028-3908(71)90018-9. [DOI] [PubMed] [Google Scholar]
  8. Lundborg P., Waldeck B. On the mechanism of amphetamine induced release of reserpine-resistant 3 H-noradrenaline and 3 H- -methylnoradrenaline. Acta Pharmacol Toxicol (Copenh) 1971;30(5):339–347. doi: 10.1111/j.1600-0773.1972.tb00665.x. [DOI] [PubMed] [Google Scholar]
  9. Menon M. K., Tseng L. F., Loh H. H. Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines. J Pharmacol Exp Ther. 1976 May;197(2):272–279. [PubMed] [Google Scholar]
  10. Myers R. D., Brophy P. D. Temperature changes in the rat produced by altering the sodium-calcium ratio in the cerebral ventricles. Neuropharmacology. 1972 May;11(3):351–361. doi: 10.1016/0028-3908(72)90021-4. [DOI] [PubMed] [Google Scholar]
  11. Reed D. J., Withrow C. D., Woodbury D. M. Electrolyte and acid-base parameters of rat cerebrospinal fluid. Exp Brain Res. 1967;3(3):212–219. doi: 10.1007/BF00235585. [DOI] [PubMed] [Google Scholar]
  12. Tseng L. F., Harris R. A., Loh N. H. Blockade of para-methoxyamphetamine- induced serotonergic effects by chlorimipramine. J Pharmacol Exp Ther. 1978 Jan;204(1):27–38. [PubMed] [Google Scholar]
  13. Tseng L. F., Menon M. K., Loh H. H. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue. J Pharmacol Exp Ther. 1976 May;197(2):263–271. [PubMed] [Google Scholar]
  14. Wong D. T., Bymaster F. P., Horng J. S., Molloy B. B. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther. 1975 Jun;193(3):804–811. [PubMed] [Google Scholar]
  15. Wong D. T., Horng J. S., Bymaster F. P., Hauser K. L., Molloy B. B. A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 1974 Aug 1;15(3):471–479. doi: 10.1016/0024-3205(74)90345-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES